{
    "2021-01-11": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Lilly Rockets On Alzheimer's News — And 3 Other Highlights From Key Health Care Meeting",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Alzheimer's",
                        "Rockets",
                        "Health Care"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Eli Lilly, Office Depot, Crocs: 5 Gainers for Monday",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Gainers",
                        "Monday"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "retail",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Here's Why Eli Lilly Broke to the Upside",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Upside"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Lilly’s Alzheimer's Drug Isn’t Worth $20 Billion Yet",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Alzheimer's",
                        "Drug",
                        "Worth"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Biogen's stock is up 5% after Lilly reports positive data from an Alzheimer's study",
                "features": {
                    "keywords": [
                        "Biogen",
                        "stock",
                        "up",
                        "Lilly",
                        "Alzheimer's",
                        "positive data"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Return On Capital Employed Overview: Eli Lilly",
                "features": {
                    "keywords": [
                        "Return",
                        "Capital Employed",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Dow Off Lows as Energy, Healthcare Rise; Democrats Eye Trump Impeachment",
                "features": {
                    "keywords": [
                        "Dow",
                        "Energy",
                        "Healthcare",
                        "Rise",
                        "Impeachment"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "energy",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Eli Lilly Stock Rockets To Record As Alzheimer's Drug Improves Cognition",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock",
                        "Rockets",
                        "Alzheimer's",
                        "Cognition"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Why Eli Lilly Stock Is Crushing It Today",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock",
                        "Crushing"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Dow Jones Today, Stocks Slump As Trump Ban Slams Twitter, Lilly Soars On Alzheimer's News, Boeing Slips After 737 Crash",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Stocks",
                        "Slump",
                        "Trump",
                        "Twitter",
                        "Lilly",
                        "Alzheimer's",
                        "Boeing",
                        "Crash"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "aerospace"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Eli Lilly Stock Gains as Drug Slows Decline in Alzheimer’s Patients",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock",
                        "Gains",
                        "Drug",
                        "Alzheimer’s",
                        "Patients"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction",
                "features": {
                    "keywords": [
                        "FDA",
                        "Jardiance",
                        "New Drug Application",
                        "heart failure"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Lilly's stock jumps 15% after experimental Alzheimer's drug shows it can slow cognitive decline",
                "features": {
                    "keywords": [
                        "Lilly",
                        "stock",
                        "jumps",
                        "Alzheimer's",
                        "cognitive decline"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Lilly's Donanemab Slows Clinical Decline of Alzheimer's Disease in Positive Phase 2 Trial",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Donanemab",
                        "Clinical Decline",
                        "Alzheimer's",
                        "Phase 2 Trial"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}